-
CMC Operations
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
1 week ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
1 week ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically e ...
-
CMC Operations
4 days ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
1 week ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations, Director
1 week ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
CMC Operations, Director
2 weeks ago
89bio San Francisco, United StatesTHE COMPANY · 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. The company's lead product candidate, pegozafermin (BIO89-100), is a specifically ...
-
VP, Technical Operations CMC
5 days ago
Rigel Pharmaceutical South San Francisco, United StatesJob Description · Job DescriptionPOSITION SUMMARY: · Responsible for providing short and long-term strategic vision, leadership, and execution of all aspects of the pharmaceutical technical operations. Provide and ensure adequate support to all pharmaceutical needs of commercial ...
-
Lead Project Manager
4 days ago
Mammoth Biosciences Brisbane, United StatesOPPORTUNITY · Mammoth Biosciences has an opening for a Lead Project Manager (PM) who will manage our growing CRISPR-based Therapeutics programs as we bring them to market. The Project Manager will be responsible for planning, oversight, and management of projects from Gene Editin ...
-
Abdera Therapeutics South San Francisco, United States**Who we are** · Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies · - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform opt ...
-
Associate Director, Formulation Development
2 weeks ago
Pliant Therapeutics, Inc. South San Francisco, United StatesPliant is conducting a Phase 1 study for its third clinical program, PLN-101095, a small molecule, dual-selective inhibitor of αvß8 and αvß1 integrins, that is being developed for the treatment of solid tumors. The Company also has discovery and development programs in oncology a ...
-
Scientist I/ii, Process Development
3 days ago
AbbVie South San Francisco, United States**Company Description** · **Key Accountabilities/Core Job Responsibilities** · - Perform routine tasks such as media/buffer preparation, thawing of cryopreserved cells, cell culture passaging, aseptic sampling and banking competently and independently to support ongoing projects ...
-
Director CMC
2 weeks ago
EPM Scientific San Francisco, United StatesDirector of CMC · Location : San Francisco, CA · Working situation : Hybrid · Level : Director · Our client, a blooming biotechnology company, is looking to expand their R&D capacity to support their growing pipeline including a new class of brain therapies. With a passion for tr ...
-
SROs Resident Manager
1 week ago
Caritas Management San Francisco, United StatesJob Description · Job Description · 1 Bedroom Apartment included in SF, CA. Manager for 44+unit SROs. · Caritas Management Corporation (CMC) was created in 1982 as an independent, for-profit subsidiary of non-profit Mission Housing Development Corporation (MHDC) to provide prof ...
-
SRO Site Director
3 weeks ago
CARITAS MANAGEMENT CORPORATION San Francisco, CA, United StatesJob Description · Job Description · Site Manager for a 214 SRO unit building. However it will remain at 50% occupancy until 2025 due to construction daily. You will have an assistant manager. · DESCRIPTION OF POSITION: The Property Manager is responsible for the daily adminis ...
CMC Operations - San Francisco, United States - snaphire
Description
CMC Operations (Drug Substance), Head of/Senior DirectorTHE COMPANY
89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases.
The company's lead product candidate, pegozafermin (BIO89-100), is a specifically engineered glycoPEGylated analog of FGF21. Pegozafermin is being developed for the treatment of nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG).THE ROLE
Reporting to the Vice President, CMC Operations, the
Head of/Senior Director CMC Operations (Drug Substance)
will manage activities related to Process Development, Tech Transfer and Manufacturing of Drug substance.
Managing complex and intertwined scientific/technical and operational logistical CMC related activities, the position will support the Company's drug development and manufacturing activities for phase 3 and commercialization at external Contract Development and Manufacturing Organization (CDMO) and Contract Testing Labs (CTL).
THE RESPONSIBILITIES
Act as the technical lead for all DS matters including DS, T2 and ST6, be responsible for resolving technical issues related to process transfer, process scale-up, COGs reduction and commercialization.
Act as the in-house validation expert and be responsible for CMC process validation including risk assessment, IPC, process characterization and validation following QbD guideline, as well as successful execution of PPQs and PAI to support BLA/MAA approval.
Manage multiple global CDMOs for tech transfer, process optimization, process scale-up and cGMP manufacturing and testing to ensure IP supply for ongoing clinical programs and commercial launch.
Manage CDMOs to optimize DS process to improve yield, quality and scalability, and reduce the product COG with the ultimate goal of developing a scalable, robust and cost-effective manufacturing process for commercialization.
Manage CDMOs to get ready for commercialization for both US and EU.Write and/or review technical documents including development reports, tech transfer reports, manufacturing batch records, campaign summary reports, risk assessment and deviation investigation reports etc.
Participate and present at the internal and external project meetings as technical SME.Participate in preparing in-process testing plan and product specifications, and ensure that test methods are in place across the vendor network to support in-process testing, lot release, stability, shelf-life extensions, and product safety.
Partner with QA for timely lot release, stability testing, deviation/OOS investigation, change control and data trending analysis etc.Write and review documents for INDs / regulatory submissions as technical SME to support regulatory interactions with the FDA and other regulatory authorities.
In coordination with QA execute plans for overall compliance; validation and registration of DS as required by cGMP, ICH, FDA, and other regulations.
THE QUALIFICATIONS
S., M.S., or equivalent in biology, biochemistry, chemical engineering, biochemical engineering or related field.
20+ years of industry experience in CMC process development, IPC testing and manufacture.
Solid working knowledge of various manufacturing platforms (Microbial fermentation process, IB recovery and refolding, CHO cell culture and purification, Pegylation, PEGylated protein purification etc.) is required.
Strong scientific knowledge on process development using DoE, process scale-up, process characterization and validation is required.Experience selecting and managing US and International external vendors (CMOs, CTLs, etc.) is required.
Experience in tech transfer and managing CDMOs on cGMP manufacturing, deviations, change controls and OOS investigations etc is required.
Late stage development and commercialization experience is required.
Experience in regulatory filings (i.e. IND, CTA, BLA etc.) is preferred.
Considerable experience working with Project/Program Management (PM) related to drug development and manufacturing.
Demonstrated history of simultaneously managing multiple projects; success working in a dynamic, fast-paced, timeline-driven environment with short lead times.
Strong people managing skills with ability to assert and influence CMOs and achieve goals.
Demonstrated strategic thinking to assess and improve processes to meet global business needs.
Superior problem-solving skills: diagnosing complex issues; developing & implementing solutions by collaborating with the appropriate internal and external stake holders.
A good team player with track record of collaborations/influence up, down and across teams/organization.Excellent written and verbal communication skills including succinctly translating complex/technical information to/for a variety of audiences .
BASE SALARY
89bio considers a range of factors when determining compensation. These considerations mean actual compensation will vary. The range for this position is $240,000 - $265,000 and will be commensurate with experience.
THE PERKS
Competitive health insurance coverage
Employee Stock Purchase Plan (ESPP)
Women's forum / mentoring
Office based in the heart of San Francisco, near plenty of shops and restaurants
Fun opportunities to engage with co-workers in-person and remotely
All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or based on disability.
Proof of Covid vaccination is a condition of employment.Notice to Recruiters:
To protect the interest of all parties, 89bio does not accept unsolicited resumes and we ask that employees, hiring managers and executives not be contacted directly.
#J-18808-Ljbffr
